<info type="DiseaseOrPhenotypicFeature">sporadic chondrocalcinosis</info> with a <info type="SequenceVariant">-4-basepair G-to-A transition</info> in the <info type="GeneOrGeneProduct">5'-untranslated region</info> of <info type="GeneOrGeneProduct">ANKH</info> that promotes enhanced expression of <info type="GeneOrGeneProduct">ANKH</info> <info type="GeneOrGeneProduct">protein</info> and excess generation of extracellular <info type="ChemicalEntity">inorganic pyrophosphate</info>.

OBJECTIVE: Certain mutations in <info type="GeneOrGeneProduct">ANKH</info>, which encodes a multiple-pass transmembrane <info type="GeneOrGeneProduct">protein</info> that regulates <info type="ChemicalEntity">inorganic pyrophosphate</info> (<info type="ChemicalEntity">PPi</info>) transport, are linked to <info type="DiseaseOrPhenotypicFeature">autosomal-dominant familial chondrocalcinosis</info>. This study investigated the potential for <info type="GeneOrGeneProduct">ANKH</info> <info type="SequenceVariant">sequence variants</info> to promote <info type="DiseaseOrPhenotypicFeature">sporadic chondrocalcinosis</info>. METHODS: <info type="GeneOrGeneProduct">ANKH</info> variants identified by genomic sequencing were screened for association with <info type="DiseaseOrPhenotypicFeature">chondrocalcinosis</info> in 128 patients with severe <info type="DiseaseOrPhenotypicFeature">sporadic chondrocalcinosis</info> or <info type="DiseaseOrPhenotypicFeature">pseudogout</info> and in ethnically matched healthy controls. The effects of specific <info type="SequenceVariant">variants</info> on expression of common markers were evaluated by in vitro transcription/translation. The function of these <info type="SequenceVariant">variants</info> was studied in transfected <info type="OrganismTaxon">human</info> immortalized <info type="CellLine">CH-8</info> articular chondrocytes. RESULTS: <info type="DiseaseOrPhenotypicFeature">Sporadic chondrocalcinosis</info> was associated with a <info type="SequenceVariant">G-to-A transition</info> in the <info type="GeneOrGeneProduct">ANKH</info> <info type="GeneOrGeneProduct">5'-untranslated region</info> (<info type="GeneOrGeneProduct">5'-UTR</info>) at <info type="SequenceVariant">4 bp</info> upstream of the start codon (in homozygotes of the minor allele, genotype relative risk <info type="ChemicalEntity">6.0</info>, <info type="ChemicalEntity">P</info> = <info type="ChemicalEntity">0.0006</info>; overall genotype association <info type="ChemicalEntity">P</info> = <info type="ChemicalEntity">0.02</info>). This <info type="SequenceVariant">-4-bp transition</info>, as well as <info type="SequenceVariant">2 mutations</info> previously linked with familial and sporadic <info type="DiseaseOrPhenotypicFeature">chondrocalcinosis</info> (<info type="SequenceVariant">+14 bp C-to-T</info> and <info type="SequenceVariant">C-terminal GAG deletion</info>, respectively), but not the <info type="DiseaseOrPhenotypicFeature">French familial chondrocalcinosis</info> kindred <info type="SequenceVariant">143-bp T-to-C mutation</info>, increased reticulocyte <info type="GeneOrGeneProduct">ANKH</info> transcription/<info type="GeneOrGeneProduct">ANKH</info> translation in vitro. Transfection of complementary DNA for both the wild-type <info type="GeneOrGeneProduct">ANKH</info> and the <info type="SequenceVariant">-4-bp ANKH protein variant</info> promoted increased extracellular <info type="ChemicalEntity">PPi</info> in <info type="CellLine">CH-8</info> cells, but unexpectedly, these <info type="SequenceVariant">ANKH mutants</info> had divergent effects on the expression of extracellular <info type="ChemicalEntity">PPi</info> and the chondrocyte hypertrophy marker, <info type="GeneOrGeneProduct">type X collagen</info>. CONCLUSION: A subset of <info type="DiseaseOrPhenotypicFeature">sporadic chondrocalcinosis</info> appears to be heritable via a <info type="SequenceVariant">-4-bp G-to-A ANKH 5'-UTR transition</info> that up-regulates expression of <info type="GeneOrGeneProduct">ANKH</info> and extracellular <info type="ChemicalEntity">PPi</info> in chondrocyte cells. Distinct <info type="GeneOrGeneProduct">ANKH</info> mutations associated with heritable <info type="DiseaseOrPhenotypicFeature">chondrocalcinosis</info> may promote <info type="DiseaseOrPhenotypicFeature">disease</info> by divergent effects on extracellular <info type="ChemicalEntity">PPi</info> and chondrocyte hypertrophy, which is likely to mediate differences in the clinical phenotypes and severity of the <info type="DiseaseOrPhenotypicFeature">disease</info>.